Physician profile
Timur Davydov
NPI 1518455187
$2,742.89
in general payments reported to CMS, 2019-2025
11 companies · $87.40 in 2025
The $87.40 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $329 · 2022: $685 · 2023: $1,221 · 2024: $421 · 2025: $87.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,333 · Travel and Lodging: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.66 |
| Travel and Lodging | $396.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,787.21 | 2022-2025 | Augment Injectable, Prostep, Hoffmann |
| Paragon 28, INC. | $396.10 | 2022 | |
| Osteomed LLC | $184.94 | 2021 | |
| Organogenesis INC. | $150.79 | 2023 | Puraply |
| Advanced Oxygen Therapy INC. | $89.64 | 2021 | |
| Melinta Therapeutics, LLC | $54.76 | 2021 | |
| Djo, LLC | $17.88 | 2025 | Cmf |
| Pacira Pharmaceuticals Incorporated | $16.74 | 2023 | Exparel |
| Smith+Nephew, INC. | $16.51 | 2023 | Grafix Pl, Stravix Pl |
| Globus Medical, INC. | $16.26 | 2025 | Senza |
| Hologic Sales and Service, LLC | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timur Davydov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.